Revenue
attach_money311M USD
-
MDGLMadrigal Pharmaceuticals, Inc.$ --
Madrigal Pharmaceuticals, Inc.
MDGL
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2026 Q1Updated: 03/31/2026
Operating Income
trending_up-93M USD
-
Net Income
verified-94M USD
-
EPS
paid-3.25$
-
Revenue
$311.3M
BEAT
$300.9M
$311.3M
$300.9M
$311.3M
Estimate (Forecast)Actual (Actual)
FY2026 Q1 YoY
- $-
Net Income
$-94.4M
BEAT
$-95.7M
$-94.4M
$-95.7M
$-94.4M
Estimate (Forecast)Actual (Actual)
FY2026 Q1 YoY
- $-
Surprise History
ActualEstimate
FY2025BEAT